0
Sign In  | Subscribe

Endocrine and Metabolism Collection
 21-40 of 103 Articles
ACP Journal Club |  18 September 2012
Glargine did not reduce CV events more than standard care in patients with dysglycemia
PDFPDF
Ellis Lader, MD
Ann Intern Med. 2012;157(6):JC3-10. doi:10.7326/0003-4819-157-6-201209180-02010
ACP Journal Club |  18 September 2012
Daily n-3 fatty acid supplements did not reduce CV events in high-risk patients with dysglycemia
PDFPDF
Ellis Lader, MD
Ann Intern Med. 2012;157(6):JC3-11. doi:10.7326/0003-4819-157-6-201209180-02011
ACP Journal Club |  21 February 2012
The optimal HbA1c cutpoint to screen for diabetes in the emergency department was 6.0%
PDFPDF
Eddy S. Lang, MD
Ann Intern Med. 2012;156(4):JC2-11. doi:10.7326/0003-4819-156-4-201202210-02011
ACP Journal Club |  17 January 2012
Insulin secretagogues were associated with increased mortality compared with metformin in type 2 diabetes
PDFPDF
Gabriela Prutsky, MD; Juan Pablo Domecq, MD; Apostolos Tsapas, MD, PhD
Ann Intern Med. 2012;156(2):JC1-7. doi:10.7326/0003-4819-156-2-201201170-02007
ACP Journal Club |  20 December 2011
Review: Intensive glucose lowering does not reduce mortality in type 2 diabetes
PDFPDF
Vijaykumar Lingegowda, MD, MSEd, FASN
Ann Intern Med. 2011;155(12):JC6-4. doi:10.7326/0003-4819-155-12-201112200-02004
ACP Journal Club |  20 December 2011
Review: Insulin to maintain normoglycemia within 24 hours of ischemic stroke does not reduce death or dependency
PDFPDF
Paul G. Wasielewski, MD; Ken Uchino, MD
Ann Intern Med. 2011;155(12):JC6-5. doi:10.7326/0003-4819-155-12-201112200-02005
ACP Journal Club |  20 December 2011
Patients with rheumatoid arthritis and those with diabetes mellitus had a similar increased risk for myocardial infarction
PDFPDF
Roland Staud, MD
Ann Intern Med. 2011;155(12):JC6-11. doi:10.7326/0003-4819-155-12-201112200-02011
ACP Journal Club |  15 November 2011
Review: Lowering systolic BP to ≤ 135 mm Hg reduces CV events in type 2 diabetes/IFG/IGT
PDFPDF
Michael E. Farkouh, MD, MSc
Ann Intern Med. 2011;155(10):JC5-3. doi:10.7326/0003-4819-155-10-201111150-02003
ACP Journal Club |  15 November 2011
Review: Cholecalciferol (vitamin D3) reduces mortality in adults; other forms of vitamin D do not
PDFPDF
Harvey J. Murff, MD, MPH
Ann Intern Med. 2011;155(10):JC5-4. doi:10.7326/0003-4819-155-10-201111150-02004
ACP Journal Club |  15 November 2011
Review: Pregabalin and other drugs reduce pain in patients with painful diabetic neuropathy
PDFPDF
Michael Tanner, MD, FACP
Ann Intern Med. 2011;155(10):JC5-8. doi:10.7326/0003-4819-155-10-201111150-02008
ACP Journal Club |  18 October 2011
Review: Intensive-dose statin therapy increases incident diabetes compared with moderate-dose therapy
PDFPDF
Elizabeth Barrett-Connor, MD
Ann Intern Med. 2011;155(8):JC4-7. doi:10.7326/0003-4819-155-8-201110180-02007
ACP Journal Club |  18 October 2011
Review: Evidence for the effectiveness of interventions to prevent foot ulcers in patients with diabetes is limited
PDFPDF
Dara L. Eckerle Mize, MD; Gunjan Y. Gandhi, MD, MSc
Ann Intern Med. 2011;155(8):JC4-8. doi:10.7326/0003-4819-155-8-201110180-02008
ACP Journal Club |  20 September 2011
Raloxifene increased bone mineral density in the spine and hips of postmenopausal women using long-term glucocorticoids
PDFPDF
John Robbins, MD
Ann Intern Med. 2011;155(6):JC3-4. doi:10.7326/0003-4819-155-6-201109200-02004
ACP Journal Club |  20 September 2011
Current use of levothyroxine was associated with increased risk for fractures in patients ≥ 70 years of age
PDFPDF
Douglas C. Bauer, MD
Ann Intern Med. 2011;155(6):JC3-5. doi:10.7326/0003-4819-155-6-201109200-02005
ACP Journal Club |  20 September 2011
Protocol-based nurse management of type 2 diabetes did not differ from usual GP care for HbA1c levels
PDFPDF
Timothy Kenealy, MD, PhD; Nicolette Sheridan, RN, PhD, MPH
Ann Intern Med. 2011;155(6):JC3-7. doi:10.7326/0003-4819-155-6-201109200-02007
ACP Journal Club |  16 August 2011
Review: Oral drugs for type 2 diabetes, alone or in combination, have different relative benefits and harms for surrogate endpoints
PDFPDF
Juan Pablo Domecq, MD; Gabriela Prutsky, MD; Victor M. Montori, MD
Ann Intern Med. 2011;155(4):JC2-4. doi:10.7326/0003-4819-155-4-201108160-02004
ACP Journal Club |  16 August 2011
Review: Rosiglitazone increases risk for cardiovascular outcomes and mortality compared with pioglitazone in type 2 diabetes
PDFPDF
Prakash Deedwania, MD
Ann Intern Med. 2011;155(4):JC2-12. doi:10.7326/0003-4819-155-4-201108160-02012
ACP Journal Club |  17 May 2011
Intensive glucose control increased mortality and did not prevent CV events compared with standard glucose control in type 2 diabetes
PDFPDF
Rozalina Grubina, MD; Steven A. Smith, MD
Ann Intern Med. 2011;154(10):JC5-2. doi:10.7326/0003-4819-154-10-201105170-02002
ACP Journal Club |  19 April 2011
HbA1c levels had low sensitivity but high specificity for screening for diabetes
PDFPDF
Lorraine Lipscombe, MD, MSc, FRCPC
Ann Intern Med. 2011;154(8):JC4-9. doi:10.7326/0003-4819-154-8-201104190-02009
ACP Journal Club |  15 March 2011
Elevated HbA1c levels (5.7% to 6.4%) had low accuracy for diagnosing prediabetes
PDFPDF
Yogish C. Kudva, MD; Ananda Basu, MD
Ann Intern Med. 2011;154(6):JC3-11. doi:10.7326/0003-4819-154-6-201103150-02011
Advertisement

Annals of Internal Medicine

Other Resources

Copyright © 2013 The American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704

Buy This Article

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Register Now for a free account
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)